| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |